Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Oric Pharmaceuticals, Inc. (ORIC) had Pre-Tax Income of $-35.77M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-35.77M |
|
-- |
|
-- |
|
$39.62M |
|
$-39.62M |
|
$3.85M |
|
|
Pre-Tax Income |
$-35.77M |
$-35.77M |
|
$-35.77M |
|
$-35.77M |
|
$-35.77M |
|
$-35.77M |
|
$-39.62M |
|
$-39.19M |
|
105.47M |
|
105.47M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$290.23M |
|
$2.15M |
|
$146.53M |
|
$436.76M |
|
$17.77M |
|
-- |
|
$3.43M |
|
$21.20M |
|
$415.56M |
|
$415.56M |
|
$415.56M |
|
103.49M |
|
| Cash Flow Statement Financials | |
$-32.44M |
|
$-17.98M |
|
$61.14M |
|
$46.16M |
|
$56.89M |
|
$10.73M |
|
$6.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.61% |
|
-8.61% |
|
-8.19% |
|
-8.61% |
|
$4.02 |
|
$-0.31 |
|
$-0.31 |
|